News & Events

2018

  • November 13, 2018Suven Life Sciences secures Product Patents in Australia and Hong KongView PDF
  • November 09, 2018Q2 & H1FY19 Schedule of conference call for InvestorsView PDF
  • November 06, 2018Suven Life Sciences secures Product Patents in Israel and JapanView PDF
  • November 05, 2018Suven Life sciences presenting at Neuroscience 2018 at San Diego, USA.View PDF
  • October 25, 2018Suven Life Sciences Ltd Announces the last patient enrolled in Phase 2 study of SUVN-502 for ModeratView PDF
  • October 23, 2018Suven to present at 11TH CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) during OCTOBER 24-27, 2018 -View PDF
  • September 25, 2018Suven Life Sciences secures Product Patents in Canada and Sri LankaView PDF
  • September 14, 2018Suven Life Sciences secures Product Patents in New Zealand and Sri LankaView PDF
  • August 29, 2018Suven Life Sciences secures Product Patents in China & EurasiaView PDF
  • August 22, 2018Suven Life Sciences secures Product & Process Patents in Canada and USAView PDF
  • August 14, 2018Suven’s Income at Rs. 1998 Mn; PAT at Rs. 388 Mn for the quarter ended June 2018View PDF
  • August 14, 2018Press ReleaseView PDF
  • August 08, 2018Q1 FY19 Schedule of conference call for InvestorsView PDF
  • August 07, 2018Suven Life Sciences secures Product Patents in Mexico and New ZealandView PDF
  • July 23, 2018Suven at Alzheimer's Association International Conference (AAIC) in Chicago.View PDF
  • July 16, 2018Suven Life Sciences secures Product Patents in Europe and South KoreaView PDF
  • July 04, 2018Suven Life Sciences secures Product Patents in India, Singapore, South Korea and IsraelView PDF
  • June 12, 2018Suven Life Sciences secures Product Patents in China and USAView PDF
  • June 08, 2018Suven Life Sciences is participating and presenting in Jefferies Global Healthcare ConferenceView PDF
  • June 01, 2018Suven Life Sciences participating at Sleep 2018 at Baltimore, MD. USA.View PDF
  • May 29, 2018Suven Life Sciences secures Product Patents in New Zealand and USAView PDF
  • May 22, 2018Suven Life Sciences secures Product Patents in New Zealand and NorwayView PDF
  • May 17, 2018Suven Life Sciences secures Product Patents in Australia and SingaporeView PDF
  • May 15, 2018Suven Revenue up by 15%; PAT up by 28% for the year ended March 2018View PDF
  • May 10, 2018Q4 FY18 Schedule of conference call for InvestorsView PDF
  • May 09, 2018Suven Life Sciences secures Product Patents in Australia, Eurasia and EuropeView PDF
  • May 07, 2018SUVEN’S Pashamylaram’s Unit Successfully completes US FDA InspectionView PDF
  • April 24, 2018USFDA InspectionView PDF
  • April 03, 2018Suven Life Sciences secures a Product Patent in Canada.View PDF
  • March 22, 2018Suven Life Sciences secures Product Patents in Norway, South Korea, and Singapore.View PDF
  • February 20, 2018Suven Life Sciences secures Product Patents in India and South KoreaView PDF
  • January 31, 2018Suven Life Sciences secures Product Patents in Aripo and South KoreaView PDF
  • January 31, 2018Q3 & 9MFY18 Conference Call TranscriptView PDF
  • January 30, 2018Suven Revenue up by 11.85%; PAT up by 15.38% for 9 months ended December’ 2017View PDF
  • January 25, 2018Q3 FY18 Schedule of conference call for InvestorsView PDF
  • January 18, 2018Suven Life Sciences secures Product Patents in China and Sri LankaView PDF
Archives